These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Gillams A; Cassoni A; Conway G; Lees W Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207 [TBL] [Abstract][Full Text] [Related]
6. Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor. Wettstein M; Vogt C; Cohnen M; Brill N; Kurz AK; Mödder U; Häussinger D Hepatogastroenterology; 2004; 51(57):830-2. PubMed ID: 15143927 [TBL] [Abstract][Full Text] [Related]
16. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver. Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323 [TBL] [Abstract][Full Text] [Related]
17. Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours. Norlén O; Stålberg P; Zedenius J; Hellman P Br J Surg; 2013 Oct; 100(11):1505-14. PubMed ID: 24037573 [TBL] [Abstract][Full Text] [Related]
18. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Mateo R; Singh G; Jabbour N; Palmer S; Genyk Y; Roman L Gynecol Oncol; 2005 Apr; 97(1):266-70. PubMed ID: 15790474 [TBL] [Abstract][Full Text] [Related]
19. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. Curtiss SI; Mor E; Schwartz ME; Sung MW; Hytiroglou P; Thung SN; Sheiner PA; Emre S; Miller CM J Am Coll Surg; 1995 Feb; 180(2):184-7. PubMed ID: 7850052 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]